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A 60-year-old woman with rheumatoid arthritis treated with methotrexate for a decade complained of 
slight epigastric discomfort.  A positive cytomegalovirus (CMV) antigenemia test indicated the proba-
bility of CMV-related gastrointestinal infection,  for which esophagogastroduodenoscopy was per-
formed.  Endoscopic ﬁndings showed a non-speciﬁc duodenal mucosal lesion; however,  pathological 
investigation revealed evidence of CMV duodenitis.  There is scarce information on the clinical and 
pathological features of CMV-related duodenitis,  likely due to its low prevalence.  CMV infection in the 
upper gastrointestinal tract should be considered as a diﬀerential diagnosis in high-risk individuals,  
particularly those with symptoms relating to the digestive system.  Biopsy examinations are preferable 
for the deﬁnitive diagnosis of CMV gastrointestinal infection,  even without speciﬁc endoscopic fea-
tures.
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ytomegalovirus (CMV) is a herpesvirus that is 
usually latent in the human body,  but has the 
potential to cause various clinical symptoms by reacti-
vating in immunocompromised hosts.  Gastrointestinal 
(GI) infections caused by CMV generally occur in the 
large intestine [1].  In the upper GI tract,  the stom-
ach and esophagus are common sites for CMV reacti-
vation whereas duodenal involvement is rare [2].  
Thus,  clinical or pathologic features of CMV infec-
tions occurring in the duodenum have scarcely been 
determined.  
　 Here,  we present a case of CMV reactivation in the 
duodenal mucosa occurring in an immunocompromised 
patient with rheumatic arthritis,  with particular 
attention given to endoscopic ﬁndings.  We consider 
that the endoscopic imaging and clinical course pre-
sented in this case report would be of use for physi-
cians treating patients with duodenal CMV infection.
Case Presentation
　 A 60-year-old woman with rheumatoid arthritis 
was admitted to our hospital owing to cellulitis on her 
upper extremities.  Her rheumatic symptoms had been 
controlled with methotrexate for approximately 10 
years.  Ten mg per week of methotrexate and 400mg 
per day of etodolac were prescribed at admission.  
There was no recent history of blood transfusion or 
Helicobacter pylori eradication.  She had never been 
treated with glucocorticoid or biological agents.  
　 CMV antigenemia (pp65. C7-HRP) was evaluated 
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on admission as part of our routine testing in immuno-
compromised patients,  and the result was found to be 
positive (20 pp65-positive cells per 5×105 cells) 
(Table 1).  CMV-speciﬁc IgM/IgG,  CD4 cell counts 
and CMV DNA copies in blood were not examined at 
that time.  Serum examination of the speciﬁc antibody 
for H. pylori was negative.  Besides the cellulitis,  the 
patient presented with epigastric discomfort,  and 
esophagogastroduodenoscopy was performed,  as we 
suspected GI involvement of CMV.  Atrophic gastritis 
was apparent in the gastric antrum.  Histology was 
positive for neutrophils and monocytes,  but negative 
for H. pylori,  atrophy and intestinal metaplasia.  Thus,  
H. pylori gastric infection was unlikely.  In the duode-
num,  on the other hand,  a reddish,  erosive edematous 
mucosa was observed in the duodenal bulb (Fig.  1).  
Partial mucosal redness was seen in the second por-
tion.  Biopsy samples were taken from the stomach,  
duodenal bulb,  and the second portion of the duode-
num.  Histology of the gastric sample was negative for 
both H. pylori infection and CMV infection.  However,  
micropathological examination of the biopsy specimen 
taken from the duodenal bulb revealed an acute inﬂam-
matory cell inﬁltration,  accompanied with aggregation 
of lymphocytes (Fig.  2A).  The presence of intranu-
clear inclusion bodies was also detected (Fig.  2B).  
Further,  CMV-positive cells were immunohistochemi-
cally observed in intraepithelial cells (Fig.  2C-D).  
No evidence of CMV infection was detected in the 
other specimens.  The complication of CMV retinitis 
was not apparent by fundus examination.  Conse-
quently,  the diagnosis of CMV duodenitis was made,  
and valganciclovir was administered after treatment 
with methotrexate was ceased.  Two weeks after the 
diagnosis of CMV duodenitis,  serum levels of CMV-
speciﬁc IgM and IgG were conﬁrmed to be 0.51 TV 
and 172U/mL,  respectively.  After 3 weeks,  although 
a follow-up endoscopic examination was not performed,  
the patientʼs symptoms had disappeared and CMV 
antigenemia was conﬁrmed to be negative.  She 
appeared to be free of GI symptom recurrence 14 
months after valganciclovir treatment was discontin-
ued.
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Fig. 1　 Endoscopic appearance of cytomegalovirus (CMV)-related duodenal lesion.  Esophagogastroduodenoscopy revealing partial red-
ness with erosion in the duodenum (A).  Narrow-band imaging emphasizing swollen villi around the erosion,  suggesting mucosal inﬂamma-
tion (B).
Table 1　 Results of laboratory examination on admission
White blood cell 4,290/mm3 LDH 383IU/L
Nt 91.0% AST 117IU/L
Lym 6.0% ALT 76IU/L
Mono 1.0% γGTP 41IU/L
Eo 1.0% T-bil 0.82mg/dL
Baso 1.0% BUN 20.6mg/dL
Hemoglobin 8.3g/dL Cre 0.61mg/dL
Platelet 28.1×104/mm3 Alb 2.9g/dL
ESR 104mm/h CRP 9.88mg/dL
Na 138mEq/L
D dimer 0.9µg/mL K 4.3mEq/L
Cl 105mEq/L
CMV-C7HR Positive CK 23IU/L
20/50,000cells HbA1c 5.5%
Discussion
　 CMV infection is a relatively common condition in 
immunocompromised patients,  although duodenal 
in volve ment is extremely rare.  Bonetti et al.  investi-
gated 30 patients with CMV infection occurring in the 
upper GI tract,  and found that the stomach is the most 
common site of involvement (63.3ｵ,  19 cases),  fol-
lowed by the esophagus (30ｵ,  9 cases),  and the car-
dia (20ｵ,  6 cases).  According to his review,  duode-
nal involvement has been seen in only one 
patient (3.3ｵ),  with multiple ulcers in the duodenum 
[2].  In a report on 9 cases of rheumatic arthritis 
patients with upper GI-tract CMV infection [3],  
duodenal lesions were seen in only 1 case.  Thus,  
clinical characteristics of CMV-related duodenal 
lesions have not been well elucidated.  The reason for 
the low occurrence rate of CMV infection in the duo-
denum is unknown,  and further investigation is 
required.
　 In general,  CMV antigenemia shows high sensitiv-
ity and speciﬁcity for viremic cases: 93.5ｵ and 
94.3ｵ,  respectively [4].  The test often yields posi-
tive results before the infection is manifested in 
organs,  thus aiding early diagnosis and pre-emptive 
therapy [5,  6].  In cases of localized CMV,  however,  
the sensitivity of the CMV antigenemia assay dra-
matically decreases [7].  Jang et al.  reported its sen-
sitivity and speciﬁcity for diagnosing GI CMV dis-
eases as 54ｵ and 88ｵ,  respectively [1].  According 
to Ozaki et al.,  who summarized 9 cases (10 events) of 
upper GI tract CMV infections in patients with rheu-
matic diseases,  the sensitivity of CMV antigenemia 
was only 50ｵ [3].  To our knowledge,  there have 
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Fig. 2　 Microscopic features of CMV-related duodenal lesion.  Results of hematoxylin and eosin staining (A,  B) and immunohistochem-
ical staining (C,  D) are shown.  The immunohistochemistry was performed using a polyvalent horseradish peroxidase polymer detection 
system (Ventana Medical Systems,  Tucson,  AZ,  USA).  Primary antibodies against anti-CMV clones DDG9 & CCH2 (M085401,  1: 100 
dilution; DAKO,  Santa Clara,  CA,  USA) were used.  Proper antigen retrieval was carried out with CC1 buﬀer for 60 min according to the 
manufacturerʼs instructions.  Inﬁltration of inﬂammatory cells (A) and the emergence of intranuclear inclusion bodies (B,  arrowhead) are 
seen in the biopsied duodenal specimen.  CMV-positive cells are sporadically observed among the intraepithelial cells (C,  D). 
been no data focusing speciﬁcally on duodenal CMV 
infection.  Thus,  the utility of the CMV antigenemia 
assay for the diagnosis of duodenal CMV infection 
should be determined hereafter.
　 Endoscopic features of CMV infection in the upper 
GI tract are generally non-speciﬁc.  Morphologies of 
CMV gastric involvement are reported to vary from 
patchy erythema to thickened mucosa,  hypertrophy of 
the gastric folds,  exudates,  erosions,  or ulcers 
[8,  2].  Similarly,  endoscopic manifestations of 
CMV-related duodenal lesions have been reported to 
be various: mucosal depigmentation [9],  ulcers with 
or without fresh bleeding [10,  11],  and even pseudo-
tumor formations [12].  It is noteworthy that the 
duodenal ulcers caused by CMV infection can lead to 
intestinal perforation,  which requires surgical treat-
ment [13].  Our case showed a reddish,  erosive 
edematous mucosa in the duodenal bulb as a manifesta-
tion of CMV-related duodenitis.  This fact implies that 
we need to recall the relevance of CMV infection for 
nonspeciﬁc mucosal lesions in the duodenum.  
　 Microscopic analysis,  rather than macroscopic 
features,  would be more important as a diagnostic tool 
for CMV-related upper GI infection.  The sensitivity 
and speciﬁcity of immunohistochemical methods for the 
diagnosis of CMV GI infection are reported to be 
higher: 89ｵ and 100ｵ,  respectively [1].  Even if 
histopathological examinations including the immuno-
histochemical staining showed negative results,  the 
intestinal CMV load may be elevated [14].  Thus,  
micropathological examinations should be taken into 
consideration for suspected GI mucosal lesions,  espe-
cially when patients are at risk of CMV infection.  In 
patients with rheumatic arthritis,  the use of glucocor-
ticoid therapy is considered a risk factor for develop-
ing the disease [3],  although our patient had never 
received steroid treatment.  We speculate that the 
methotrexate treatment was mainly responsible for 
immunosuppression in this case,  leading to the reacti-
vation of CMV.  CMV-speciﬁc IgM/IgG,  CD4 cell 
counts and CMV DNA copies in blood were not exam-
ined at her initial presentation.  In the future,  these 
data,  in addition to the medication history,  should be 
collected from individual cases with CMV-related 
upper GI infection,  since doing so will promote a bet-
ter understanding of the etiology and epidemiology of 
this disease entity.
　 Mucous membrane disorders of the duodenum have 
various etiologies.  Representative conditions include 
use of non-steroidal anti-inflammatory agents 
(NSAIDs) and H. pylori infection.  The patient had 
taken etodolac,  a kind of NSAID,  for the purpose of 
rheumatic pain control.  The drug is a cyclooxyge-
nase-2 selective inhibitor,  which is less damaging to 
the mucous membrane of the gastrointestinal tract.  
Endoscopic ﬁndings showed atrophic gastritis;  
however,  the result of micropathological examination 
denied evidence of H. pylori infection,  and her serum 
specimen was negative for the speciﬁc antibody for H. 
pylori.  Thus,  the relevance of H. pylori infection was 
unlikely in our case.  
　 In conclusion,  we have reported a case of CMV 
duodenitis,  in which the mucosal lesion presented a 
non-speciﬁc manifestation on endoscopy ﬁndings.  
Though rare,  CMV infection in the upper GI tract 
should be included in the diﬀerential diagnoses of 
immunocompromised patients with GI manifestations.  
Even when the lesion appears non-speciﬁc,  biopsy 
sampling and pathological investigations can lead to the 
diagnosis of CMV infection in the upper GI tract.
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